Actively Recruiting
Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot and Other Congenital Heart Diseases
Led by Mayo Clinic · Updated on 2026-02-05
300
Participants Needed
1
Research Sites
256 weeks
Total Duration
On this page
Sponsors
M
Mayo Clinic
Lead Sponsor
N
National Heart, Lung, and Blood Institute (NHLBI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study is being done to determine the mechanism(s) contributing to the onset of symptoms (i.e. shortness of breath and/or palpitations) as well as changes in heart structure in patients with congenital heart disease (CHD)
CONDITIONS
Official Title
Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot and Other Congenital Heart Diseases
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Moderate (or greater) pulmonary regurgitation based on quantitative Doppler echocardiography
- Repaired Tetralogy of Fallot
- Diagnosis of congenital heart disease including but not limited to Ebstein's anomaly, coarctation of the aorta, Fontan palliation, transposition of the great arteries, or congenitally corrected transposition of the great arteries
You will not qualify if you...
- Pregnant women
- Unable to undergo cardiac MRI (CMRI)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905
Actively Recruiting
Research Team
H
Halley Davison
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here